Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology
- PMID: 30609739
- PMCID: PMC6337145
- DOI: 10.3390/ijms20010141
Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology
Abstract
Alpha-synuclein (α-syn) is a small protein that, in neurons, localizes predominantly to presynaptic terminals. Due to elevated conformational plasticity, which can be affected by environmental factors, in addition to undergoing disorder-to-order transition upon interaction with different interactants, α-syn is counted among the intrinsically disordered proteins (IDPs) family. As with many other IDPs, α-syn is considered a hub protein. This function is particularly relevant at synaptic sites, where α-syn is abundant and interacts with many partners, such as monoamine transporters, cytoskeletal components, lipid membranes, chaperones and synaptic vesicles (SV)-associated proteins. These protein⁻protein and protein⁻lipid membrane interactions are crucial for synaptic functional homeostasis, and alterations in α-syn can cause disruption of this complex network, and thus a failure of the synaptic machinery. Alterations of the synaptic environment or post-translational modification of α-syn can induce its misfolding, resulting in the formation of oligomers or fibrillary aggregates. These α-syn species are thought to play a pathological role in neurodegenerative disorders with α-syn deposits such as Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), which are referred to as synucleinopathies. Here, we aim at revising the complex and promiscuous role of α-syn at synaptic terminals in order to decipher whether α-syn molecular interactants may influence its conformational state, contributing to its aggregation, or whether they are just affected by it.
Keywords: conformational plasticity; interactome; synaptic proteins; synucleinopathies; α-synuclein.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.Nature. 2015 Jun 18;522(7556):340-4. doi: 10.1038/nature14547. Epub 2015 Jun 10. Nature. 2015. PMID: 26061766
-
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.Alzheimers Res Ther. 2020 Nov 30;12(1):159. doi: 10.1186/s13195-020-00727-x. Alzheimers Res Ther. 2020. PMID: 33256825 Free PMC article.
-
Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.Parkinsonism Relat Disord. 2020 Dec;81:48-53. doi: 10.1016/j.parkreldis.2020.10.016. Epub 2020 Oct 8. Parkinsonism Relat Disord. 2020. PMID: 33049589
-
From onset to advancement: the temporal spectrum of α-synuclein in synucleinopathies.Ageing Res Rev. 2025 Feb;104:102640. doi: 10.1016/j.arr.2024.102640. Epub 2024 Dec 10. Ageing Res Rev. 2025. PMID: 39667671 Review.
-
The Synaptic Function of α-Synuclein.J Parkinsons Dis. 2015;5(4):699-713. doi: 10.3233/JPD-150642. J Parkinsons Dis. 2015. PMID: 26407041 Free PMC article. Review.
Cited by
-
Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro.Acta Neuropathol Commun. 2021 Nov 24;9(1):188. doi: 10.1186/s40478-021-01288-2. Acta Neuropathol Commun. 2021. PMID: 34819159 Free PMC article.
-
NMDA and AMPA Receptors at Synapses: Novel Targets for Tau and α-Synuclein Proteinopathies.Biomedicines. 2022 Jun 29;10(7):1550. doi: 10.3390/biomedicines10071550. Biomedicines. 2022. PMID: 35884851 Free PMC article. Review.
-
Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases.Biomolecules. 2021 May 20;11(5):767. doi: 10.3390/biom11050767. Biomolecules. 2021. PMID: 34065606 Free PMC article. Review.
-
Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson's disease.Front Pharmacol. 2023 Feb 2;14:1088957. doi: 10.3389/fphar.2023.1088957. eCollection 2023. Front Pharmacol. 2023. PMID: 36817162 Free PMC article.
-
Navigating the dynamic landscape of alpha-synuclein morphology: a review of the physiologically relevant tetrameric conformation.Neural Regen Res. 2020 Mar;15(3):407-415. doi: 10.4103/1673-5374.265792. Neural Regen Res. 2020. PMID: 31571649 Free PMC article. Review.
References
-
- Kahle P.J., Neumann M., Ozmen L., Muller V., Jacobsen H., Schindzielorz A., Okochi M., Leimer U., van Der Putten H., Probst A., et al. Subcellular localization of wild-type and Parkinson’s disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J. Neurosci. 2000;20:6365–6373. doi: 10.1523/JNEUROSCI.20-17-06365.2000. - DOI - PMC - PubMed
-
- Abeliovich A., Schmitz Y., Farinas I., Choi-Lundberg D., Ho W.H., Castillo P.E., Shinsky N., Verdugo J.M., Armanini M., Ryan A., et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 2000;25:239–252. doi: 10.1016/S0896-6273(00)80886-7. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous